These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36868589)

  • 1. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
    Mukora R; Maraba N; Orrell C; Jennings L; Naidoo P; Mbatha MT; Velen K; Fielding K; Charalambous S; Chetty-Makkan CM
    BMJ Open; 2023 Mar; 13(3):e065202. PubMed ID: 36868589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
    Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
    Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
    Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
    PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
    Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a brief motivational interview and text message intervention targeting tobacco smoking, alcohol use and medication adherence to improve tuberculosis treatment outcomes in adult patients with tuberculosis: a multicentre, randomised controlled trial of the ProLife programme in South Africa.
    Louwagie G; Kanaan M; Morojele NK; Van Zyl A; Moriarty AS; Li J; Siddiqi K; Turner A; Mdege ND; Omole OB; Tumbo J; Bachmann M; Parrott S; Ayo-Yusuf OA
    BMJ Open; 2022 Feb; 12(2):e056496. PubMed ID: 35165113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study.
    Leung CL; Alacapa J; Tasca BG; Villanueva AD; Masulit S; Ignacio ML; Uy KN; Pell C; van Kalmthout K; Powers R; Fielding K; Jerene D
    JMIR Hum Factors; 2024 Jul; 11():e54117. PubMed ID: 39042889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
    Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
    Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.
    Moriarty AS; Louwagie GM; Mdege ND; Morojele N; Tumbo J; Omole OB; Bachmann MO; Kanaan M; Turner A; Parrott S; Siddiqi K; Ayo-Yusuf OA
    Trials; 2019 Jul; 20(1):457. PubMed ID: 31349850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
    Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
    J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions and acceptability of short message services technology to improve treatment adherence amongst tuberculosis patients in Peru: a Focus Group Study.
    Albino S; Tabb KM; Requena D; Egoavil M; Pineros-Leano MF; Zunt JR; García PJ
    PLoS One; 2014; 9(5):e95770. PubMed ID: 24828031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
    Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
    Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Marconi VC
    BMC Med; 2022 Sep; 20(1):310. PubMed ID: 36167528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
    Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
    Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study.
    Drabarek D; Anh NT; Nhung NV; Hoa NB; Fox GJ; Bernays S
    PLoS One; 2019; 14(7):e0219891. PubMed ID: 31329610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
    Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
    BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying contextual determinants of problems in tuberculosis care provision in South Africa: a theory-generating case study.
    Murdoch J; Curran R; van Rensburg AJ; Awotiwon A; Dube A; Bachmann M; Petersen I; Fairall L
    Infect Dis Poverty; 2021 May; 10(1):67. PubMed ID: 33971979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
    Wei X; Hicks JP; Pasang P; Zhang Z; Haldane V; Liu X; Yin T; Wang L; Shi D; Ge S; Walley J; Upshur R; Hu J
    Trials; 2019 May; 20(1):273. PubMed ID: 31097023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial.
    Musiimenta A; Atukunda EC; Tumuhimbise W; Pisarski EE; Tam M; Wyatt MA; Ware NC; Haberer JE
    JMIR Mhealth Uhealth; 2018 May; 6(5):e122. PubMed ID: 29773527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.